Evidence map›Paper›PMID 17724149›Full record

ReviewAntimicrobial agents and chemotherapy2008

Quinolone-mediated bacterial death.

Karl Drlica, Muhammad Malik, Robert J Kerns, Xilin Zhao

Abstract readReview
In one paragraph

Review in Antimicrobial agents and chemotherapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 234 papers.

0numbers the graph read from it
0cells of the map it votes in
234citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

234 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Stationary-phasemSphere · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Quinolone Resistance and Zoonotic Potential ofAntibiotics (Basel, Switzerland) · 2025
    Article
  18. Article
  19. Article
  20. Article

174 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Karl DrlicaPublic Health Research Institute, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, 225 Warren St., Newark, NJ 07103, USA. drlica@phri.org
Muhammad Malik
Robert J Kerns
Xilin Zhao

Funding

Novel fluoroquinolones for killing dormant Mycobacterium tuberculosisR01AI073491 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI DRLICA, KARL A, KERNS, ROBERT JOHN · 2007 to 2015
$5.1M
DNA GYRASE AND QUINOLONE RESISTANCE IN TUBERCULOSISR01AI035257 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI DRLICA, KARL A · 1993 to 2007
$4.3M
New genes involved in cellular responses to quinolone treatmentR21AI068014 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI ZHAO, XILIN · 2007 to 2008
$425k
Quinolone Action During Mycobacterial Growth ArrestR21AI063431 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI DRLICA, KARL A · 2005 to 2006
$346k
NIAID NIH HHS AI063431NIAID NIH HHS AI073491NIAID NIH HHS AI35257NIAID NIH HHS R01 AI035257NIAID NIH HHS R01 AI073491NIAID NIH HHS R21 AI063431NIAID NIH HHS R21 AI068014
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBacteriaDNA TopoisomerasesModels, MolecularQuinolonesAnti-Bacterial AgentsDNA TopoisomerasesQuinolones

Identifiers

PMID17724149
PMCPMC2224783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.